{
"main_header": {
"sid": 1281869,
"name": "Sight Sciences, Inc.",
"stock_name": "Sight Sciences, Inc.",
"full_name": "Sight Sciences, Inc.",
"name_url": "stocks-analysis/sight-sciences-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "6.12",
"chg": -0.35,
"chgp": "-5.41%",
"dir": -1,
"prev_price": "6.47",
"mcapval": "337.32",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2325,
"indexname": "S&P 500",
"isin": "US82657M1053",
"curr_date": "Feb 04",
"curr_time": "",
"bse_nse_vol": "554.37 k",
"exc_status": "Active",
"traded_date": "Feb 04, 2026",
"traded_date_str": "2026 02 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sight-sciences-inc-1281869-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Sight Sciences, Inc. Hits New 52-Week High at USD 5.86",
"link": "https://www.marketsmojo.com/news/stocks-in-action/sight-sciences-inc-hits-new-52-week-high-at-usd-586-3686449",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SightSciencesIn_priceRelatedfactors_3686449.png",
"date": "2025-11-10 17:13:52",
"description": "Sight Sciences, Inc. has achieved a new 52-week high of USD 5.86, significantly up from its low of USD 2.03. With a market capitalization of USD 193 million, the company, despite losses and a negative return on equity, has outperformed the S&P 500 over the past year."
}
],
"total": 5,
"sid": "1281869",
"stock_news_url": "https://www.marketsmojo.com/news/sight-sciences-inc-1281869"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}
Sight Sciences, Inc. Hits New 52-Week High at USD 5.86
2025-11-10 17:13:52Sight Sciences, Inc. has achieved a new 52-week high of USD 5.86, significantly up from its low of USD 2.03. With a market capitalization of USD 193 million, the company, despite losses and a negative return on equity, has outperformed the S&P 500 over the past year.
Read full news articleNo announcement available
Corporate Actions
No corporate action available
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."






